The drug, developed by Professor Guangyi LIANG of CAS Key Laboratory of Chemistry for Natural Products in Guizhou, is based on chemically synthesized key components of hepatitis B virus which are easy to produce, and has been shown in preclinical studies to be efficient, have a unique site of action and does not lead to resistance.

Chine Bio news release, August 22, 2014